International Journal of Biological Sciences
ISSN: 1449-2288
Global reach, higher impact
Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938 This issue Cite
Retraction
Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Published 2021-10-8
Citation:
International Journal of Biological Sciences. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938. https://www.ijbs.com/v17p4092.htm
Other stylesRetracted-article in Int J Biol Sci, Volume 10, 404
This article (Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Qian-Qian Zhang, Yi Ding, Yan Lei, et al. Int J Biol Sci 2014; 10(4): 404-414) has been retracted due to concerns on multiple image duplications as identified by PubPeer users. This raises concerns about the integrity of the data presented in the paper.
Citation styles
APA
International Journal of Biological Sciences (2021). Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. International Journal of Biological Sciences, 17(15), 4092. https://doi.org/10.7150/ijbs.66938.
ACS
International Journal of Biological Sciences Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int. J. Biol. Sci. 2021, 17 (15), 4092. DOI: 10.7150/ijbs.66938.
NLM
International Journal of Biological Sciences. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938. https://www.ijbs.com/v17p4092.htm
CSE
International Journal of Biological Sciences. 2021. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci. 17(15):4092.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.